Delivery Order SPE2DB22D3501-SPE2DB24FUM58
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,774,936 units of Ondansetron HCL 4 mg tablets. The award, valued at $2,928.70, is a delivery order with a firm fixed price. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,564,558,882 units of Ondansetron HCl 4 mg tablets. The award, valued at $16,651.68, is a delivery order contract with a firm fixed price structure and a completion date of May 10, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $4,646.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,105,874 units of the pharmaceutical drug Ondansetron HCL 4 mg Tablet. The contract has a completion date of December 15, 2023 and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,566,166,114 units of Ondansetron HCL 4 mg tablets, with a ceiling value of $15,834.86 and a completion date of October 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $9,782.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,416,379 units of Ondansetron HCL 4 mg Tablets in 30-count packages. This is a delivery order contract with a firm fixed-price pricing type, with a completion date of April 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $4,235.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,559,735,862 units of the pharmaceutical product Ondansetron HCL 4 mg Tablet in 30-count packages. The contract has a completion date of January 27, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,954,458 units of Ondansetron HCL 4 mg tablets. The contract, valued at $4,013.25, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DX15D2205|SPE2DX24F75DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,032,242 units of Ondansetron HCL 4 mg tablets in 30-count packages, with a total ceiling value of $8,976.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 8, 2023....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,565,134,591 units of Ondansetron HCL 4 mg tablets in quantities of 500 per bottle. The contract has a ceiling value of $31,456.95 and an ultimate completion date of July 15, 2024. It was awarded on a Firm Fixed Price basis as a Delivery Order by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency component of the Department of Defense. Amerisourcebergen holds a...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $27,047.14, is for the delivery of 4,560,924,536 units of the medication ondansetron hydrochloride 4 mg tablets. The contract has a completion date of May 15, 2023 and is structured as a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...